Epidiolex
Epidiolex ingredients
| Active ingredient | Strength |
|---|---|
| Cannabidiol | 100 mg/mL |
What Epidiolex is used for
The FDA lists the approved uses on the official label (below). In the EU, cannabidiol is approved as Epidyolex for:
Epidyolex is indicated for use as adjunctive therapy of seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome (DS), in conjunction with clobazam, for patients 2 years of age and older.
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Epidiolex
- Generic name
- Cannabidiol
- Made by
- Jazz Pharmaceuticals, Inc.
- Forms
- Solution
- Given
- Oral
- FDA approval
- New drug application (NDA) NDA210365
- On the US market since
- 2018
Official information
- Epidiolex prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Cannabidiol)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Epidiolex?
Epidiolex (Cannabidiol) is a specialist medicine made by Jazz Pharmaceuticals, Inc., approved by the US FDA.
What are the ingredients of Epidiolex?
Epidiolex contains Cannabidiol (100 mg/mL).
Is Epidiolex approved in Europe?
The same active substance is approved in the EU as Epidyolex.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA